Table 2.
n | Tumor cells [%] | Necrosis [%] | Fibrosis [%] | |
SW620 | 5 | 60 (30–70) | 40 (10–60) | 10 (0–20) |
HCT116 | 7 | 70 (20–90) | 10 (5–60) | 20 (0–20) |
HT29 | 8 | 65 (10–80) | 15 (5–80) | 20 (10–20) |
Rectal cancer biopsies | 10 | 35 (10–98) | 0 (0-0) | 28 (0–60) |
Percentage viable tumor cells, necrosis and fibrosis in the HR MAS MRS analyzed tissue samples from untreated SW620, HCT116, HT29 and human rectal cancer biopsies. Results are given as median and range.